Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-19 Purchase |
2020-11-23 5:30 pm |
Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director |
197,716 | $15.12 | $2,989,466 | 2,827,883 (Indirect) |
View |
| 2020-11-17 Purchase |
2020-11-19 8:15 pm |
Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director |
29,394 | $15.29 | $449,400 | 2,630,167 (Indirect) |
View |
| 2020-07-21 Purchase |
2020-07-23 4:50 pm |
Pandion Therapeutics Inc. | PAND | ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner |
36,111 | $18 | $649,998 | 3,086,084 (Indirect) |
View |
| 2020-07-21 Purchase |
2020-07-23 4:49 pm |
Pandion Therapeutics Inc. | PAND | Mutz Mitchell Director 10% Owner |
46,111 | $18 | $829,998 | 10,000 (Indirect) |
View |
| 2020-07-21 Purchase |
2020-07-22 4:30 pm |
Pandion Therapeutics Inc. | PAND | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
361,111 | $18 | $6,499,998 | 1,770,023 (Indirect) |
View |
| 2020-07-21 Purchase |
2020-07-22 4:18 pm |
Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner |
361,111 | $18 | $6,499,998 | 2,262,301 (Indirect) |
View |
| 2020-07-21 Purchase |
2020-07-21 7:51 pm |
Pandion Therapeutics Inc. | PAND | Polaris Partners GP VIII L.L.C. Polaris Entrepreneurs' Fund VIII L.P. Polaris Partners VIII L.P. 10% Owner |
36,111 | $18 | $649,998 | 110,621 (Indirect) |
View |
| 2020-07-21 Purchase |
2020-07-21 7:49 pm |
Pandion Therapeutics Inc. | PAND | Boxer Capital LLC Boxer Asset Management Inc. Braslyn Ltd. LEWIS JOSEPH Davis Aaron I. MVA Investors LLC 10% Owner |
722,222 | $18 | $12,999,996 | 2,131,135 (Indirect Direct) |
View |
| 2020-07-21 Purchase |
2020-07-21 7:47 pm |
Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner |
361,111 | $18 | $6,499,998 | 2,262,301 (Indirect) |
View |
| 2020-07-21 Purchase |
2020-07-21 7:44 pm |
Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner |
50,111 | $18 | $901,998 | 545,090 (Indirect Direct) |
View |
| 2020-07-21 Purchase |
2020-07-21 7:44 pm |
Pandion Therapeutics Inc. | PAND | Fuglesang Christopher Director 10% Owner |
722,222 | $18 | $12,999,996 | 2,614,770 (Indirect Direct) |
View |
| 2020-07-21 Purchase |
2020-07-21 7:39 pm |
Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director 10% Owner |
723,222 | $18 | $13,017,996 | 2,615,770 (Indirect Direct) |
View |
| 2020-07-21 Purchase |
2020-07-21 7:39 pm |
Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks |
1,450 | $18 | $26,100 | 115,991 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-04-01 Equity Swap |
2021-04-01 7:59 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Viney Joanne L. See Remarks |
504,454 | $60 | 0 (Direct) |
View |
| 2021-04-01 Equity Swap |
2021-04-01 7:58 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks |
87,764 | $60 | 0 (Direct) |
View |
| 2021-04-01 Equity Swap |
2021-04-01 7:57 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner |
3,621,894 | $60 | 0 (Direct) |
View |
| 2021-04-01 Equity Swap |
2021-04-01 7:55 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Freedman Edward D. Chief Operating Officer |
54,460 | $60 | 0 (Direct) |
View |
| 2021-04-01 Equity Swap |
2021-04-01 7:53 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | BELOFF GREGG See Remarks |
13,196 | $60 | 0 (Indirect) |
View |
| 2021-04-01 Equity Swap |
2021-04-01 7:50 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Kakkar Rahul Chief Executive Officer |
716,515 | $60 | 0 (Direct) |
View |
| 2021-04-01 Equity Swap |
2021-04-01 7:49 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Fuglesang Christopher Director 10% Owner |
2,131,135 | $60 | 0 (Indirect) |
View |
| 2021-04-01 Equity Swap |
2021-04-01 7:49 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director |
2,828,883 | $60 | 0 (Direct) |
View |
| 2021-04-01 Equity Swap |
2021-04-01 7:46 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Sundy John Chief Medical Officer |
115,826 | $60 | 0 (Direct) |
View |
| 2021-04-01 Equity Swap |
2021-04-01 7:46 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Stagliano Nancy Director |
74,067 | $60 | 0 (Direct) |
View |
| 2021-04-01 Equity Swap |
2021-04-01 7:45 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Frail Donald Director |
61,113 | $60 | 0 (Direct) |
View |
| 2021-04-01 Equity Swap |
2021-04-01 7:43 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner |
5,674,221 | $60 | 0 (Indirect) |
View |
| 2021-04-01 Equity Swap |
2021-04-01 7:37 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Larson Eric D Vice President, Finance |
22,125 | $60 | 0 (Direct) |
View |
Ownership |
2021-03-04 06:06 am |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Merck & Co. Inc. MERCK SHARP & DOHME CORP. 10% Owner |
0 | $0 | 0 (Indirect) |
View |
| 2021-02-08 Option Award |
2021-02-10 4:47 pm |
N/A 2031-02-07 |
Pandion Therapeutics Inc. | PAND | Kakkar Rahul Chief Executive Officer |
221,367 | $0 | 221,367 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 4:46 pm |
N/A 2031-02-07 |
Pandion Therapeutics Inc. | PAND | Freedman Edward D. Chief Operating Officer |
36,895 | $0 | 36,895 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 4:45 pm |
N/A 2031-02-07 |
Pandion Therapeutics Inc. | PAND | Viney Joanne L. See Remarks |
73,789 | $0 | 73,789 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 4:41 pm |
N/A 2031-02-07 |
Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks |
73,789 | $0 | 73,789 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 4:41 pm |
N/A 2031-02-07 |
Pandion Therapeutics Inc. | PAND | Larson Eric D Vice President, Finance |
23,000 | $0 | 23,000 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 4:40 pm |
N/A 2031-02-07 |
Pandion Therapeutics Inc. | PAND | Sundy John Chief Medical Officer |
73,789 | $0 | 73,789 (Direct) |
View |
| 2020-12-02 Option Award |
2020-12-04 8:04 pm |
N/A 2030-12-01 |
Pandion Therapeutics Inc. | PAND | Dorton Katina Director |
27,994 | $0 | 27,994 (Direct) |
View |
Ownership |
2020-12-04 7:58 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Dorton Katina Director |
0 | $0 | 0 (Direct) |
View |
| 2020-07-21 Conversion |
2020-07-23 4:50 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner |
18,602,976 | $0 | 3,086,084 (Indirect) |
View |
| 2020-07-21 Conversion |
2020-07-23 4:49 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Mutz Mitchell Director 10% Owner |
18,602,976 | $0 | 10,000 (Indirect) |
View |
| 2020-07-21 Conversion |
2020-07-22 4:30 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner |
8,593,508 | $0 | 1,770,023 (Indirect) |
View |
| 2020-07-17 Option Award |
2020-07-22 4:18 pm |
N/A 2030-07-16 |
Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner |
13,997 | $0 | 2,262,301 (Indirect) |
View |
| 2020-07-21 Conversion |
2020-07-22 4:18 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | GLAXOSMITHKLINE PLC Director 10% Owner |
11,510,727 | $0 | 2,262,301 (Indirect) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:51 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Polaris Partners GP VIII L.L.C. Polaris Entrepreneurs' Fund VIII L.P. Polaris Partners VIII L.P. 10% Owner |
19,306,473 | $0 | 110,621 (Indirect) |
View |
| 2020-07-17 Option Award |
2020-07-21 7:49 pm |
N/A 2030-07-16 |
Pandion Therapeutics Inc. | PAND | Mutz Mitchell Director 10% Owner |
13,997 | $0 | 13,997 (Direct) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:49 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Boxer Capital LLC Boxer Asset Management Inc. Braslyn Ltd. LEWIS JOSEPH Davis Aaron I. MVA Investors LLC 10% Owner |
8,593,509 | $0 | 2,131,135 (Direct) |
View |
| 2020-07-17 Option Award |
2020-07-21 7:47 pm |
N/A 2030-07-16 |
Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner |
13,997 | $0 | 2,262,301 (Indirect) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:47 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Carroll Jill Director 10% Owner |
11,510,727 | $0 | 2,262,301 (Indirect) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:45 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | JDRF T1D Fund LLC 10% Owner |
2,506,728 | $0 | 426,333 (Direct) |
View |
| 2020-07-17 Option Award |
2020-07-21 7:44 pm |
N/A 2030-07-16 |
Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner |
13,997 | $0 | 545,090 (Direct) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:44 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Crane Alan L Director 10% Owner |
19,435,374 | $0 | 545,090 (Indirect) |
View |
| 2020-07-17 Option Award |
2020-07-21 7:44 pm |
N/A 2030-07-16 |
Pandion Therapeutics Inc. | PAND | Fuglesang Christopher Director 10% Owner |
13,997 | $0 | 2,614,770 (Direct) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:44 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Fuglesang Christopher Director 10% Owner |
8,593,509 | $0 | 2,614,770 (Indirect) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:41 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
21,530,967 | $0 | 3,754,051 (Direct) |
View |
| 2020-07-17 Option Award |
2020-07-21 7:39 pm |
N/A 2030-07-16 |
Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director 10% Owner |
13,997 | $0 | 2,615,770 (Direct) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:39 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director 10% Owner |
11,458,013 | $0 | 2,615,770 (Indirect) |
View |
| 2020-07-17 Option Award |
2020-07-21 7:39 pm |
N/A 2030-07-16 |
Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks |
28,227 | $0 | 115,991 (Direct) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:39 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Goyal Vikas See Remarks |
42,966 | $0 | 115,991 (Direct) |
View |